1985
DOI: 10.1016/s0140-6736(85)91345-5
|View full text |Cite
|
Sign up to set email alerts
|

Does Chorionic Villus Sampling Cause Fetomaternal Haemorrhage?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
15
0
1

Year Published

1990
1990
2017
2017

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 50 publications
(20 citation statements)
references
References 5 publications
4
15
0
1
Order By: Relevance
“…Out of the 44 infants with Rh-D HDFN 20 (45.5%) belonged to low risk, 13 Regarding blood product transfusion, 9 (20.5%) transfused packed red blood cells, 3 (6.8%) transfused platelet concentrate and 2 (4.5%) transfused fresh frozen plasma. Results of intensity of treatment was 20 (45.5%) belonged to grade 0, 13 (29.5%) to grade 1, 7 (15.9%) to grade 2, 3 (6.8%) grade 3 and 1 (2.3%) to grade 4 category of treatment.…”
Section: Amongmentioning
confidence: 99%
See 1 more Smart Citation
“…Out of the 44 infants with Rh-D HDFN 20 (45.5%) belonged to low risk, 13 Regarding blood product transfusion, 9 (20.5%) transfused packed red blood cells, 3 (6.8%) transfused platelet concentrate and 2 (4.5%) transfused fresh frozen plasma. Results of intensity of treatment was 20 (45.5%) belonged to grade 0, 13 (29.5%) to grade 1, 7 (15.9%) to grade 2, 3 (6.8%) grade 3 and 1 (2.3%) to grade 4 category of treatment.…”
Section: Amongmentioning
confidence: 99%
“…13 Walker et al noticed that the risk of stillbirth in a woman who previously delivered mildly affected infant was 2%, whereas in a woman who delivered one previous stillbirth was as high as 70%. 7 In this analysis, eleven mothers of infants with Rh-D HDFN had undergone postpartum RhIG prophylaxis during previous deliveries.…”
Section: Amongmentioning
confidence: 99%
“…A imunização prévia no sistema Rh também é outro fator para a contra-indicação da BVC porque, indubitavelmente, essa biópsia induz à mistura de sangue materno e fetal (Warren et al, 1985). Para casais com filhos anteriores portadores de malformações não devidas a alterações cromossômicas, mas para as quais há suspeita de que possa haver recorrência (por exemplo, malformações de membros, malformações cranianas, malformações múltiplas etc.)…”
Section: Contra-indicaçõesunclassified
“…CVS does not appear to alter the fetal growth potential (Williams et al 1987) nor does it induce changes in the fetal behavioural state (Boogert et al 1987). Based on serum AFP determinations, feto-maternal transfusion occurs in 50% of the patients as a result of the procedure (Warren et al 1985). However, no correlation has been found between the number of catheter insertions, gestational age at sampling, or milligrams of tissue sampled and the occurrence of feto-maternal haemorrhage (Warren et al 1985).…”
Section: Introductionmentioning
confidence: 99%
“…Based on serum AFP determinations, feto-maternal transfusion occurs in 50% of the patients as a result of the procedure (Warren et al 1985). However, no correlation has been found between the number of catheter insertions, gestational age at sampling, or milligrams of tissue sampled and the occurrence of feto-maternal haemorrhage (Warren et al 1985). The risk of spontaneous abortion after CVS has been evaluated by a number of investigators and is approximately 4% in experienced units (Jahoda et al 1985;Brambati et al 1987).…”
Section: Introductionmentioning
confidence: 99%